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Humans are considered as the main host for Mycobacterium leprae1, the aetiological 
agent of leprosy, but spillover has occurred to other mammals that are now 
maintenance hosts, such as nine-banded armadillos and red squirrels2,3. Although 
naturally acquired leprosy has also been described in captive nonhuman primates4–7, 
the exact origins of infection remain unclear. Here we describe leprosy-like lesions in 
two wild populations of western chimpanzees (Pan troglodytes verus) in Cantanhez 
National Park, Guinea-Bissau and Taï National Park, Côte d’Ivoire, West Africa. 
Longitudinal monitoring of both populations revealed the progression of disease 
symptoms compatible with advanced leprosy. Screening of faecal and necropsy 
samples confirmed the presence of M. leprae as the causative agent at each site and 
phylogenomic comparisons with other strains from humans and other animals show 
that the chimpanzee strains belong to different and rare genotypes (4N/O and 2F). 
These findings suggest that M. leprae may be circulating in more wild animals  
than suspected, either as a result of exposure to humans or other unknown 
environmental sources.
Leprosy is a neglected tropical disease caused by the bacterial patho-
gens M. leprae and the more recently discovered Mycobacterium lep-
romatosis8,9. In humans, the disease presents as a continuum of clinical 
manifestations with skin and nerve lesions of increasing severity, from 
the mildest tuberculoid form (or paucibacillary) to the most severe 
lepromatous type (or multibacillary)10. Symptoms develop after a long 
incubation period ranging from several months to 30 years, averaging 
5 years in humans. As a result of sensory loss, leprosy can lead to per-
manent damage and severe deformity11. Although leprosy prevalence 
has markedly decreased over recent decades, approximately 210,000 
new human cases are still reported every year, of which 2.3% are located 
in West Africa12. Transmission is thought to occur primarily between 
individuals with prolonged and close contact via aerosolized nasal 
secretions and entry through nasal or respiratory mucosae, but the 
exact mechanism remains unclear13,14. The role of other routes, such 
as skin-to-skin contact, is unknown.
Leprosy-causing bacteria were once thought to be obligate human 
pathogens1. However, they can circulate in other animal hosts in 
the wild, such as nine-banded armadillos (Dasypus novemcinctus) 
in the Americas and red squirrels (Sciurus vulgaris) in the UK2,3. 
Although initial infection was most probably incidental and of 
human origin, secondary animal hosts can subsequently represent a 
source of infection to humans15–18. In captivity, nonhuman primates, 
such as chimpanzees (Pan troglodytes)4, sooty mangabeys (Cercoce-
bus atys)5,6 and cynomolgus macaques (Macaca fascicularis)7, have 
been known to develop leprosy without any obvious infectious source. 
However, due to their captive status, it is unclear how they acquired 
M. leprae and whether these species can also contract leprosy in 
the wild.
Here, we report leprosy infections and their disease course in two 
wild populations of western chimpanzees (P. troglodytes verus) in Can-
tanhez National Park (CNP), Guinea-Bissau, and in Taï National Park 
(TNP), Côte d’Ivoire, using a combination of camera trap and veterinary 
monitoring (Extended Data Fig. 1a and Supplementary Notes 1 and 2). 
From analyses of faecal samples and postmortem tissues, we identified 
M. leprae as the causative agent of the lesions observed and determined 
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the phylogenetic placement of the respective strains based on their 
complete genome sequences.
Chimpanzees at CNP are not habituated to human observers, pre-
cluding systematic behavioural observations. Longitudinal studies 
necessitate the use of camera traps, which we operated between 2015 
and 2019. Of 624,194 data files (videos and photographs) obtained 
across 211 locations at CNP (Extended Data Fig. 1b, Extended Data 
Table 1 and Supplementary Table 1), 31,044 (5.0%) contained chim-
panzees. The number of independent events (images separated by 
at least 60 min) totalled 4,336, and of these, 241 (5.6%) contained 
chimpanzees with severe leprosy-like lesions, including four clearly 
identifiable individuals (two adult females and two adult males) 
across three communities (Extended Data Fig. 2 and Supplementary 
Note 2). As with humans, paucibacillary cases in chimpanzees may 
be present but easily go undetected. Such minor manifestations of 
leprosy are not reported. All symptomatic chimpanzees showed hair 
loss and facial skin hypopigmentation, as well as plaques and nodules 
that covered different areas of their body (limbs, trunk and genitals), 
facial disfigurement and ulcerated and deformed hands (claw hand) 
and feet (Fig. 1a–c), consistent with a multibacillary form of the disease. 
Longitudinal observations showed progression of symptoms across 
time with certain manifestations similar to those described in humans 
(such as progressive deformation of the hands) (Extended Data Fig. 2 
and Supplementary Videos 1–3). To confirm infection with M. leprae, we 
collected faecal samples and tested them with two nested polymerase 
chain reaction (PCR) assays targeting the M. leprae-specific repetitive 
element (RLEP) and 18 kDa antigen gene. One out of 208 DNA extracts 
from CNP was positive in both assays and a second was positive only in 
the more sensitive RLEP-PCR19 (Extended Data Table 2, Supplementary 
Table 2 and Supplementary Note 3). Microsatellite analyses of the two 
positive samples confirmed that they originated from two distinct 
female individuals (Supplementary Note 4 and Supplementary Tables 3 
and 4). Our results suggest that M. leprae is the most likely cause of a 
leprosy-like syndrome in chimpanzees from CNP.
At TNP, chimpanzees are habituated to the presence of researchers 
and have been followed daily since 1979. In addition, necropsy samples 
have been collected from all dead individuals recovered since 2000. 
In June 2018, researchers first noticed leprosy-like lesions on Wood-
stock, an adult male chimpanzee from one of the three habituated com-
munities (south) (Extended Data Fig. 1c). The initial small nodules on the 
ears, lips and under the eye became more prominent and were followed 
by nodules on the eyebrows, eyelids, nostrils, ears, lips and face. The 
skin on facial nodules, hands, feet and testicles became hypopigmented 
and the loss and abnormal growth of nails was observed (Fig 1d–g, 
Extended Data Fig. 3 and Supplementary Videos 4 and 5). Mycobacte-
rium leprae DNA was detected in all samples from June 2018 (Extended 
Data Table 2, Supplementary Table 2 and Supplementary Note 2). 
Here, continuous noninvasive detection of M. leprae was associated 
with the onset and evolution of a leprosy-like disease.
Retrospective PCR screening of all chimpanzee spleen samples 
(n = 38 individuals) from the TNP necropsy collection led to the identifi-
cation of M. leprae DNA in two further individuals. An adult female from 
the same community named Zora, who had been killed by a leopard 
in 2009, tested positive in both PCR assays. The presence of M. leprae 
DNA was confirmed by PCR in various other organs (Extended Data 
Table 2). Retrospective analyses of photographs taken in the years 
before her death showed progressive skin hypopigmentation and nod-
ule development since 2007 (Extended Data Fig. 3). Formalin-fixed 
skin samples (hands and feet) were prepared for histopathological 
examination using haematoxylin and eosin as well as Fite-Faraco stains. 
The skin presented typical signs of lepromatous leprosy characterized 
by a diffuse cutaneous cell infiltration in the dermis and the subcutis 
clearly separated from the basal layer of the epidermis (Extended Data 
Fig. 4a). We detected moderate numbers of acid-fast bacilli (single or 
in clumps) within histiocytes, indicative of M. leprae (Extended Data 
Fig. 4b). As antibodies against the M. leprae-specific antigen phenolic 
glycolipid-I (PGL-I) are a hallmark of M. leprae infection in humans20, 
we also performed a PGL-I lateral flow rapid test21 on a blood sample 
from this individual, which showed strong seropositivity (Extended 
Data Fig. 4c). Faecal samples collected in the years before Zora’s death 
contained M. leprae DNA from 2002 onwards, implying at least 7 years of 
infection (Extended Data Table 2). In this case, disease manifestations, 
histopathological findings, serological and molecular data, as well as 
the overall course of the disease, all unambiguously point towards 
M. leprae-induced leprosy.
To ascertain whether other individuals in the south community of 
TNP were infected at the time of Zora’s death in 2009, cross-sectional 
screening of contact animals (n = 32) was performed by testing all 
available faecal samples (n = 176) collected in 2009 (Supplementary 
Table 2). Three other chimpanzees were PCR-positive in single samples, 
including Woodstock. Clinical symptoms of leprosy have not been 
observed in other individuals, despite daily monitoring of south com-
munity members for 20 years and of neighbouring communities for 40 
years22,23. Considering that, over this period, 467 individuals have been 
observed, it seems that leprosy is a rare disease with low transmission 
levels in these chimpanzee communities.
To characterize the M. leprae strains causing leprosy in wild chim-
panzees and to perform phylogenomic comparisons, we selected DNA 
extracts that were positive in both the RLEP and the less-sensitive 18-kDa 
PCR, which indicates relatively high levels of M. leprae DNA. For TNP, we 
selected individuals that were positive in multiple samples. Following 
targeted enrichment using hybridization capture, samples were sub-







Fig. 1 | Clinical manifestations of leprosy in three chimpanzees at CNP, 
Guinea-Bissau and TNP, Côte d’Ivoire. a–c, Clinical signs of leprosy in two 
adult female chimpanzees in CNP (images extracted from camera traps). a, Rita 
has large hypopigmented nodules covering the entire body; disfigurement of 
the face, ears, hands and feet (ulcerated lesions and swelling). b, Rita has 
extensive plaques covering all limbs, with hair loss. c, Brinkos has large 
hypopigmented nodules covering the entire face, with extreme disfigurement 
of the face and ears, and ulcerated plaques on the arms and the nipples.  
d–g, Clinical signs of leprosy in an adult male chimpanzee, Woodstock, at TNP. 
d, Multiple hypopigmented nodules on the ears, brow ridges, eyelid margins, 
nostrils, lips and the area between the upper lip and the nose.  
e, Hypopigmentation and swelling of the hands with ulcerations and hair loss 
on the dorsal side of the joints. f, Claw hand with nail loss and abnormal 
overgrowth of fingernails. g, Scrotal reddening and ulceration with fresh 
blood.
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was obtained for sample GB-CC064 (Guinea-Bissau) and for Zora (Côte 
d’Ivoire) with mean depth of 39.3× and 25.8×, respectively (Extended 
Data Table 2 and Supplementary Table 5). We generated 21 M. leprae 
genomes from human biopsies from five West African countries (Niger, 
Mali, Benin, Côte d’Ivoire and Senegal) and depth of coverage ranged 
from 4.7× to 170×. We assembled a dataset that included the genomes 
generated in this study and all previously available M. leprae genomes. 
Of the total 286 genomes, 64 originated from six West African countries 
(Extended Data Fig. 5 and Supplementary Note 5).
Bayesian and maximum-parsimony analyses (Extended Data Figs. 6 
and 7) place the strain from Guinea-Bissau (GB-CC064) on branch 4, 
where it clusters outside the standard genotypes 4N, 4O and 4P, but 
within the so-called 4N/O genotype24,25 (Fig. 2a, c). This 4N/O genotype is 
rare and only comprises five M. leprae strains; one strain (Ng13-33) from 
a patient in Niger, two strains (2188-2007 and 2188-2014) obtained from 
a single patient in Brazil (of 34 strains in Brazil)26 and two strains from 
two captive nonhuman primates originating from West Africa (Ch4 
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Fig. 2 | Phylogeny of M. leprae strains from human and animal hosts.  
a, Bayesian dated phylogenetic tree of 278 M. leprae genomes including the two 
new chimpanzee strains (in bold red). Hypermutated samples with mutations 
in the nth gene were excluded from the analysis. The tree is drawn to scale, with 
branch lengths representing years of age. Median estimates of node ages are 
shown in black above branches; 95% HPD intervals are shown in grey. Some 
M. leprae branches are collapsed to increase readability. b, Maximum 
parsimony tree of branch 2F. c, Maximum parsimony tree of the branch 4. The 
tree was initially constructed using 286 genomes (Supplementary Table 6), 
including 2 new chimpanzee strains (in bold red) and 21 new genomes from 
West Africa (in bold), 500 bootstrap replicates and M. lepromatosis as 
outgroup. Sites with missing data were partially deleted (80% genome 
coverage cutoff), resulting in 4,470 variable sites used for the tree calculation. 
Subtrees corresponding to branches were retrieved in MEGA765. 
Corresponding genotypes are indicated on the side of each subtree. Samples 
are binned according to geographical origin as given in the legend. Scale bars 
(b, c), number of nucleotide substitutions. Animal silhouettes are available 
under Public Domain licence at PhyloPic (http://PhyloPic.org/).
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was unresolved in our analyses, with a basal polytomy suggestive of 
star-like diversification within this genotype, and within the group 
comprising all genotype 4 strains (4N/O, 4N, 4P and 4O). Divergence 
from the most recent common ancestor for this group is estimated to 
have occurred in the sixth century ad (mean divergence time, 1,437 
years ago, 95% highest posterior density (HPD) 1,132–1,736 years ago). 
The strain that infected Zora in Côte d’Ivoire, designated TNP-418, 
belongs to branch 2F, within which, the branching order was also mostly 
unresolved (Fig. 2a, b). The branch is currently composed of human 
strains from medieval Europe (n = 7) and modern Ethiopia (n = 2), and 
this genotype has thus far never been reported to our knowledge in 
West Africa. Bayesian analysis estimated a divergence time during the 
second century ad (mean of 1,873 years ago (95% HPD 1,564–2,204 years 
ago)), similar to previous predictions27.
Samples from Woodstock did not yield enough Illumina reads 
to reconstruct full genomes for phylogenomic analysis. However, 
single-nucleotide polymorphisms (SNPs) recovered from the few avail-
able Illumina reads and Sanger sequences derived from PCR products 
allowed us to assign this second M. leprae strain from Côte d’Ivoire 
to the same genotype as TNP-418 (Supplementary Note 5). Overall, 
phylogenomic analyses show that M. leprae strains in chimpanzee 
populations at CNP and TNP are not closely related.
The finding of M. leprae-induced leprosy in wild chimpanzee popula-
tions raises the question of the origin(s) of these infections. Mycobac-
terium leprae is considered a human-adapted pathogen and previous 
cases of leprosy affecting wildlife were compatible with anthropono-
sis. Therefore, the prime hypothesis would be human-to-chimpanzee 
transmission. Potential routes of transmission include direct (such 
as skin-to-skin) contact and inhalation of respiratory droplets and/
or fomites, with the assumption that, in all cases, prolonged and/or 
repeated exposure is required for transmission11. Chimpanzees at CNP 
are not habituated to humans and are not approached at distances 
that would allow for transmission via respiratory droplets. Although 
these chimpanzees inhabit an agroforest landscape and share access to 
natural and cultivated resources with humans28, present-day human–
chimpanzee direct contact is uncommon. The exact nature of historic 
human–chimpanzee interactions at CNP remains, however, unknown. 
For example, robust data on whether chimpanzees were kept as ‘pets’ 
or were hunted for meat are lacking. Long-term human–chimpanzee 
coexistence in this shared landscape makes humans the most prob-
able source of chimpanzee infection. However, multiple individuals 
from several chimpanzee communities across CNP show symptomatic 
leprosy demonstrating that M. leprae is now probably transmitted 
between individuals within this population.
At TNP, the south chimpanzee community is distant from human set-
tlements and agriculture. Human-to-animal transmission of pathogens 
has been shown at TNP29,30 but involved respiratory pathogens (pneumovi-
ruses and human coronavirus OC43) that transmit easily and do not require 
prolonged exposure. In addition, M. leprae is thought to be transmitted 
from symptomatic humans31 and no cases of leprosy have been reported 
among researchers or local research assistants. Although a human source 
is impossible to rule out, low human contact coupled with the rarity of 
the M. leprae genotype detected in TNP chimpanzees among human 
populations in West Africa suggests that recent human-to-chimpanzee 
transmission is unlikely. This is supported by the absence of drug-resistant 
mutations (Supplementary Note 6). The relatively old age of the lineage 
leading to the chimpanzee strain at TNP nevertheless raises the possibility 
of an ancient human-to-chimpanzee transmission. However, the human 
population density 1,500–2,000 years ago was probably even lower than 
it is currently, making this unlikely. If such an ancient transmission had 
occurred and the bacterium had persisted for a long time in chimpanzees, 
it should have spread more broadly as observed in M. leprae-infected squir-
rels and armadillos3,16,17. Therefore, an ancient human-to-chimpanzee 
transmission is not the most plausible mechanism to explain the presence 
of M. leprae in chimpanzees at TNP.
These findings may be better explained by the presence of a nonhu-
man leprosy reservoir. As chimpanzees hunt frequently, transmission 
may originate from their mammalian prey32. Nonhuman primates are 
the most hunted prey at TNP33 and are hunted at CNP (Supplementary 
Note 3). Chimpanzees also consume other mammalian prey such as 
ungulates. Notably, this scenario assumes that the animal host range 
of M. leprae is even broader than is currently known. Perhaps more 
intriguingly, an environmental source may be at the origin of chim-
panzee infections. Other mycobacteria can survive in water, including 
M. ulcerans and other non-tuberculous mycobacteria34,35, and molecu-
lar investigations have reported that M. leprae can survive in soil36. 
Experimental data also show that M. leprae multiplies in amoebae37, 
arthropods38 and ticks39, which could contribute to the persistence of 
the bacteria in the environment. Testing these hypotheses will require 
thorough investigation of the distribution of M. leprae in wildlife and 
the environment and so shed light on the overall transmission pathways 
of the pathogen.
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Methods
Study sites
Observational study and sample collections were performed at CNP 
in southern Guinea-Bissau and TNP in western Côte d’Ivoire (Extended 
Data Fig. 1a). CNP (1,067 km2) comprises the Cubucaré peninsula in 
the sector of Bedanda, with the northeast of the park bordering the 
Republic of Guinea. The landscape at CNP consists of a mosaic of mainly 
mangroves, subhumid forest patches, savannah grassland and wood-
land, remnant forest strips dominated by palm groves as well as agri-
culture40. There are approximately 200 villages and settlements within 
the borders of the park, with an estimated human population of 24,000 
individuals who comprise several ethnic groups41. Chimpanzees are 
not hunted for consumption within CNP due to local cultural beliefs 
and taboos42 but are sometimes killed in retaliation for foraging on 
crops43,44. There is a minimum of 12 chimpanzee communities at CNP41, 
all unhabituated to researchers, with approximately 35–60 individuals 
per community45,46. Numerous other wildlife taxa inhabit CNP, includ-
ing six other nonhuman primate species41,47.
The TNP (5,082 km2) consists of an evergreen lowland rainforest 
and is the largest remaining primary forest fragment in West Africa. 
It is home to a wide range of mammals that include 11 different non-
human primate species48,49. There are no settlements or agricultural 
areas inside the National Park. As of March 2021, the three habituated 
communities, north, south and east, comprised 22, 37 and 32 indi-
viduals, respectively, although community sizes have varied over time. 
Systematic health monitoring of these communities has been ongoing 
since 200023.
Longitudinal observations and health monitoring
At CNP, camera traps (Bushnell Trophy Cam models 119774, 119877 
and 119875) were deployed at 211 locations, including across different 
habitat types (forest, mangrove-forest edge and orchards) within the 
home range of 8 of the 12 putative chimpanzee communities (Sup-
plementary Table 1). Camera traps were set up over six data collection 
periods from 2015 to 2019 (Extended Data Table 1). Targeted camera 
traps were deployed to record and monitor chimpanzee behaviour 
and disease occurrence. To maximize the chances of recording spe-
cific behaviours and to identify leprosy-like symptoms in individuals, 
targeted camera traps were set up in locations that chimpanzees were 
known to use most often, sometimes in clusters, precluding uniform 
survey designs. Targeted camera traps were set up in video mode and 
were active 24 h per day. When triggered, targeted cameras recorded 10 
to 60 s of video with a minimum interval of 0.6 s or 2 s, depending on the 
camera trap model. Furthermore, systematically placed camera traps 
were used to obtain measures of wildlife occurrence and habitat use 
across the heterogeneous landscape41. Systematic camera traps were 
deployed across central CNP, at a minimum distance of 1 km between 
sampling points, as well as within the home range of one chimpanzee 
community (Caiquene-Cadique) and were spaced at least 500 m from 
one another. The camera traps pointed towards animal paths (often 
chimpanzee paths), small human paths also used by wildlife and other 
areas presenting signs of animal activity. Systematic camera traps were 
set up to record three consecutive photographs when triggered. The 
GPS coordinates, habitat type, date, time and site description were 
recorded when setting up individual camera traps (targeted and sys-
tematic). Opportunistic observations of chimpanzees at CNP were 
made in 2013, during which chimpanzees were photographed and/or 
filmed using digital cameras.
Chimpanzees at TNP are fully habituated to human observers and all 
individuals in the habituated communities are individually identified. 
Behavioural and health monitoring of chimpanzees at TNP involves 
daily observation of habituated individuals by an interdisciplinary team 
comprising primatologists and veterinarians; investigations of wildlife 
mortality causes through necropsies on all animal carcasses found 
in the research area; and the collection of noninvasive samples such 
as faecal samples, laboratory investigations and the communication 
of the results to the park management for corrective and preventive 
measures22. Abnormalities in behaviour or clinical signs of disease 
are immediately reported and followed by detailed observation by 
the on-site veterinarian. To reduce the risk of transmission of human 
diseases to the chimpanzees, stringent hygiene measures have been 
put in place, including an initial 5-day quarantine for observers, keeping 
a distance of at least 7 m and obligatory wearing of masks, with only 
healthy observers allowed to work in the forest50,51.
Faecal and necropsy sample collection
At CNP, chimpanzee faecal samples were collected between July 2017 
and December 2018. The date and putative chimpanzee community 
were recorded for each faecal sample. As defecation was rarely observed 
and to prevent the collection of redundant samples from the same 
individual, we avoided multiple samples found under the same chim-
panzee nest and paid special attention if multiple samples were found 
in proximity on trails45,52,53. All samples were collected with the aid of 
a wooden spatula and stored at ambient temperature in 15-ml tubes 
containing NAP buffer54. All samples were sent to the Robert Koch Insti-
tute for laboratory analysis. Even though chimpanzee faeces are easily 
distinguishable from those of other species and were found in areas 
where chimpanzees had recently been present with associated signs 
such as feeding remains or knuckle prints, we genetically confirmed 
the presence of chimpanzee DNA in faecal samples that tested positive 
in either of the M. leprae PCRs or the mammal PCR for diet analysis 
(Supplementary Note 3).
At TNP, the long-term health monitoring programme includes 
continuous collection of faecal and urine samples from known adult 
chimpanzees. Faeces are collected right after defecation, transferred to 
2-ml cryotubes with the aid of a plastic spatula and frozen in liquid 
nitrogen the same day. A full necropsy is systematically performed 
on chimpanzees found dead by the on-site veterinarian. Necropsies 
follow a standardized biosafety protocol due to the occurrence of 
anthrax, Ebola and monkeypox in the area. This includes the use of 
full personal protective equipment and rigorous disinfection meas-
ures. Tissue samples of several internal organs are taken if the state of 
carcass decomposition allows. After collection, all samples are first 
stored in liquid nitrogen and subsequently shipped on dry ice to the 
Robert Koch Institute for analyses.
DNA extraction from faeces and necropsy samples
DNA extractions were performed at the Robert Koch Institute in a 
laboratory that has never been used for molecular M. leprae investi-
gations. DNA was extracted from faecal and necropsy samples using 
the GeneMATRIX stool DNA purification kit (EURx) and the DNeasy 
Blood and Tissue kit (QIAGEN), respectively, following the manufactur-
ers’ instructions. Extracted DNA was then quantified using the Qubit 
dsDNA HS Assay kit (Thermo Fisher Scientific) and subsequently stored 
at −20 °C until further use.
Genetic identification of samples from infected chimpanzees at 
CNP
To determine whether faecal samples positive for M. leprae belonged 
to one or two individuals at CNP, we amplified chimpanzee DNA at 11 
microsatellite loci and one sexing marker55. Owing to the small quantity 
of starting DNA, not all loci were amplified and in some cases the ampli-
fication quality was low, affecting our ability to confidently interpret 
allele peak profiles (for example, sample GB-CC064 failed to amplify 
for 5 out of the 11 loci) (Supplementary Note 4).
Molecular screening of M. leprae in faecal and necropsy samples
Mycobacterium leprae DNA was searched for using two nested PCR 
systems targeting the distinct but conserved repetitive element RLEP 
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and the 18-kDa antigen gene as previously described (Extended Data 
Table 3). As 37 copies of RLEP are present in the M. leprae genome, this 
assay is considered to be more sensitive than 18 kDa, for which there is 
only a single copy. To prevent contamination at the laboratory at the 
Robert Koch Institute and to enable us to identify whether it occurs, we 
followed these procedures: (1) separate rooms were used for prepara-
tion of PCR master mixes and the addition of DNA in the primary PCR; 
(2) the addition of the primary PCR product in the nested PCR in another 
separate room; and (3) dUTPs were used for all PCRs instead of dNTPs. 
For both assays, primary PCRs were performed in 20-µl reactions: up 
to 200 ng of DNA was amplified using 1.25 U of high-fidelity Platinum 
Taq polymerase (Thermo Fisher Scientific), 10× PCR buffer, 200 µM 
dUTPs, 4 mM MgCl2 and 200 nM of both forward and reverse primers. 
The thermal cycling conditions for the primary and nested PCRs were 
as follows: denaturation at 95 °C for 3 min, followed by 50 cycles of 
95 °C for 30 s, 55 °C (18 kDa primers) or 58 °C (RLEP primers) for 30 s, 
and 72 °C for 1 min as well as an elongation step at 72 °C for 10 min. For 
nested PCRs, 2 µl of a 1:20 dilution of the primary PCR product was 
used as a template. Molecular-grade water was used as a template-free 
control. PCR products were visualized on a 1.5% agarose gel stained with 
GelRed (Biotium). Bands of the expected size were purified using the 
Purelink Gel extraction kit (Thermo Fisher Scientific). Both RLEP and 
18-kDa nested PCR products are too short for direct Sanger sequenc-
ing. Therefore, fusion primers (primary PCR primers coupled with 
M13F and M13R primers) (Extended Data Table 3) were used for further 
amplification of the cleaned PCR products, applying the same condi-
tions as in the primary PCR, but running only for 25 cycles. The result-
ing extended PCR products were then enzymatically cleaned using 
the ExoSAP-IT PCR Product Cleanup assay (Thermo Fisher Scientific) 
and Sanger sequenced using M13 primers. Resulting sequences were 
compared to publicly available nucleotide sequences using the Basic 
Local Alignment Search Tool (BLAST)56.
Histopathology
To further confirm the infection, skin samples were sent to the German 
Primate Center in Göttingen, Germany for histopathological analy-
ses. Samples were immersion-fixed in 10% neutral-buffered formalin, 
embedded in paraffin and stained with standard haematoxylin and 
eosin using the Varistain Gemini staining automat (Thermo Fisher 
Scientific). Samples were also stained with Fite-Faraco stain for the 
identification of acid-fast bacilli.
Serology
A whole-blood sample from Zora collected during the necropsy in 
2009 was tested for the presence of the M. leprae-specific anti-PGL-I 
antibodies using a chromatographic immunoassay developed for use 
with human blood following the instructions provided by the test manu-
facturers with a 1:10 diluted whole-blood sample. This rapid lateral flow 
test was produced by R. Cho using the synthetic ND-O-BSA antigen 
with financial support of the NIH/NIAID Leprosy Research Materials 
contract AI-55262 at Colorado State University. Test results were inter-
preted at 5 and 10 min. Human serum from a patient with multibacillary 
leprosy donated by J. S. Spencer, Colorado State University, was used 
as a positive control. Whole blood collected during the necropsy of a 
chimpanzee (Olivia) at TNP who died of acute respiratory disease in 
2009 was used as a negative control.
Library preparation, genome-wide capture and 
high-throughput sequencing for nonhuman primate samples
Selected M. leprae-positive faecal and necropsy samples (Supple-
mentary Table 2) were converted into dual-indexed libraries using 
the NEBNext Ultra II DNA Library Prep kit (New England Biolabs)57,58. 
To reconstruct whole genomes, libraries were target-enriched for 
M. leprae DNA using in-solution hybridization capture with 80-nt RNA 
baits designed to cover the whole M. leprae genome (twofold tiling; 
design can be shared upon request to the corresponding author) and 
following the myBaits protocol as previously described25. Around 1.5 µg 
of each DNA library was captured in single or pooled reactions. Two 
rounds of 24-h hybridization capture were performed followed by a 
post-amplification step for each using the KAPA HiFi HotStart Library 
Amplification kit with 12 to 16 cycles to generate around 200 ng of 
enriched library per sample. Finally, enriched libraries were purified 
using the silica-based MinElute reaction cleanup kit (QIAGEN) followed 
by quantification with the KAPA library quantification kit (Roche). 
Libraries were then normalized and pooled across sequencing lanes 
on an Illumina NextSeq 500 for sequencing with a mid-output kit v.2 
for 300 cycles (Illumina).
Sample collection, DNA extraction, library preparation, 
genome-wide capture and high-throughput sequencing of 
human specimens
Samples (skin biopsies or DNA extracts) from patients with leprosy 
from five West African countries who had a positive bacillary index 
(Niger (n = 5), Mali (n = 8), Benin (n = 6), Côte d’Ivoire (n = 1) and Senegal 
(n = 1)) were obtained from the respective National Leprosy Control 
Programmes in the framework of the leprosy drug-resistance surveil-
lance programmes or from previous investigation59.
DNA was extracted from skin biopsies using the total DNA extraction 
method as described previously60. DNA was quantified with a Qubit 
fluorometer using the Qubit dsDNA BR Assay kit (Thermo Fisher Scien-
tific) before library preparation. DNA libraries were prepared using the 
KAPA Hyper Prep kit (Roche) as per the manufacturer’s recommenda-
tion using KAPA Dual-Indexed Adapter (Roche) followed by in-solution 
capture enrichment with 80-nt RNA baits with 2× tiling density for 
48 h at 65 °C as described previously60. Post-capture amplification was 
performed with seven cycles. Enriched libraries were purified using a 
1× ratio of KAPA Pure beads (Roche) followed by quantification with 
the KAPA library quantification kit (Roche) and quality control of the 
fragment with the Agilent 2200 TapeStation (Agilent Technologies). 
Libraries were then normalized and pooled across sequencing lanes 
on an Illumina NextSeq 500 for sequencing with a high output kit v.2 
for 75 cycles (Illumina).
Genomic data analysis
Raw reads were processed as described elsewhere24. Putative unique 
variants of GB-CC064 and TNP-418 strains were manually checked and 
visualized using the Integrative Genomics Viewer61.
Genome-wide comparison and phylogenetic tree
SNPs of the two newly sequenced genomes from chimpanzees were 
compared to the 263 publicly available M. leprae genomes25,60,62–64 
(Supplementary Table 6) and 21 new genomes from West African 
countries (Supplementary Note 5). Phylogenetic analyses were per-
formed using a concatenated SNP alignment (Supplementary Table 7). 
Maximum-parsimony trees were constructed in MEGA765 with the 286 
genomes available (Supplementary Table 5) using 500 bootstrap rep-
licates and M. lepromatosis66 as outgroup. Sites with missing data were 
partially deleted (80% genome coverage cutoff), resulting in 4,470 
variable sites used for the tree calculation.
Dating analysis
Dating analyses were performed using BEAST2 (v.2.5.2)67 as described 
previously24 with 278 genomes and an increased chain length from 
50 to 100 million. In brief, concatenated SNPs for each sample were 
used for tip dating analysis (Supplementary Table 7). Hypermutated 
strains and highly mutated genes associated with drug resistance (in 
yellow, Supplementary Table 7) were omitted24,60, manual curation of 
the maximum parsimony and BEAST input file was conducted at the 
positions described in Supplementary Table 9 for GB-CC064 and TNP-
418. Sites with missing data as well as constant sites were included in the 
analysis, as previously described24. Only unambiguous constant sites 
(loci where the reference base was called in all samples) were included.
PCR genotyping of insufficiently covered M. leprae genomes 
from positive chimpanzees
The genome coverage for the strain infecting Woodstock was low. 
To be able to determine the genotype, we identified specific variants 
from the genome-wide comparison of TNP-418 (the strain infecting 
Zora, an individual from the same social group) with other strains from 
branch 2F (Supplementary Table 9). Variants were manually checked 
and visualized in the partially covered genome from the strain infecting 
Woodstock using IGV software (Supplementary Table 10). Two variants 
not covered by high-throughput sequencing data were also selected 
for specific PCR screening. Primers were designed using the Primer3 
web tool (http://bioinfo.ut.ee/primer3-0.4.0/) based on Mycobrowser 
sequences68 and are described in Extended Data Table 3. All PCR condi-
tions were the same as in the M. leprae screening PCRs except for the 
primer sets and associated annealing temperatures.
Ethical oversight
For chimpanzees, all data were collected in accordance with Best Prac-
tice Disease and Monitoring Guidelines developed by the Section on 
Great Apes, IUCN SSC Primate Specialist Group (IUCN SSC PSG SGA). 
The collection of samples was noninvasive. All proposed data collec-
tion and analyses adhered strictly to ethics guidelines of the Asso-
ciation for the Study of Animal Behaviour (UK). Ethical approval for 
targeted leprosy camera trap surveys and faecal sample collection 
at CNP, Guinea-Bissau, was granted by the University of Exeter, UK. 
The Institute for Biodiversity and Protected Areas in Guinea-Bissau 
approved and collaborated directly on all aspects of this research. 
Ethical approval for the work by the Taï Chimpanzee Project at TNP was 
given by the Ethics Commission of the Max Planck Society. The Centre 
Suisse de Recherches Scientifiques en Côte d’Ivoire collaborates on 
the research at TNP.
For human participants, this study was carried out under the ethical 
consent of the World Health Organization Global Leprosy Program 
surveillance network. All human participants gave written informed 
consent in accordance with the Declaration of Helsinki.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
Sequence data are available from the National Center for Biotechnol-
ogy Information Sequence Read Archive, BioProject (PRJNA664360) 
and BioSample (16207289–16207321). BioSample codes for all samples 
used in this study are given in the Supplementary Data. Other relevant 
data are available in the Article and its Supplementary Information.
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Extended Data Fig. 1 | Maps of the chimpanzee study sites and chimpanzee 
communities. a, Map of the CNP, Guinea-Bissau and the TNP, Côte d’Ivoire, 
West Africa. b, Location of the chimpanzee communities at CNP that were 
monitored between 2015 and 2019 (1, Caiquene-Cadique; 2, Lautchande; 3, 
Cambeque; 4, Cabante; 5, Canamine; 6, Madina; 7, Amindara; 8, Guiledje). 
Estimated home ranges of chimpanzee communities at CNP are shown by 
100% minimum convex polygons of direct chimpanzee observations and 
indirect chimpanzee traces and nests during the study period. Red outline 
represents chimpanzee communities with at least one individual with clinical 
manifestations of leprosy, confirmed using molecular analysis; orange outline 
represents chimpanzee communities with at least one individual with clinical 
manifestations of leprosy; yellow colour represents monitored communities 
where clinical manifestations of leprosy have not been observed nor confirmed 
through molecular analysis. c, Location of the three habituated chimpanzee 
communities monitored at TNP (N, north; S, south; E, east). Estimated home 
ranges of chimpanzee communities at TNP are shown by 100% minimum 
convex polygons of direct chimpanzee follows from December 2013 to October 
2016. Red outline represents the community with individuals with clinical 
manifestations of leprosy, confirmed using molecular analysis and serological 
tests; blue colour represents communities where leprosy has not been 
recorded.
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Extended Data Fig. 2 | Disease progression of leprosy in chimpanzees at 
CNP. Adult female chimpanzee Rita over the course of 5 years (a–d) and disease 
manifestations in three additional adult chimpanzees (e–g). a, 2013/05 – 
Hypopigmentation of skin around the mouth and nose, small nodule on the 
lower lip and left ear (opportunistically recorded with a video camera before 
the start of longitudinal health monitoring with camera traps). b, 2015/12 – 
Large nodules between the upper lip and nose, with multiple small nodules on 
the eyelids, cheek, ears margins, lower lip and brow ridge. Small dry patches 
with hair loss on the wrists, knees and elbows. c, 2017/12 – Nodules increase in 
number, with apparent swelling and reddening, facial disfigurement and claw 
hand. Plaques appear on the wrist, knee and elbow joints, with an increase in 
hair thinning. d, 2018/05 – Face and ears completely covered by large nodules, 
with facial disfigurement and generalized hair loss on limbs and lower back. 
Nodule formation and swelling of fingers and toes, with disfigurement of 
hands and feet, and more severe claw hand. Some plaques on the body are 
ulcerated, and the individual has clear weight loss. e, Jimi (Lautchande in 
2018/06) – First observation of lesions in 2015. The head is completely covered 
with multiple nodules of reddish colour, some of which are ulcerated. Ear 
margins are thickened. Hands and feet present nodules and plaques, and the 
scrotum is affected (not visible on picture). f, Baaba (Cambeque in 2017/08) 
– First observation of lesions in 2017. Multiple hypopigmented nodules on 
the brow ridge, cheek and upper and lower lips. Ears have thickened margins 
and nodules. There is hair thinning, with multiple small plaques present 
on the upper and lower limbs, back, abdomen and shoulders. g, Brinkos 
(Caiquene-Cadique in 2018/10) – First observation of lesions in 2015. Facial 
disfigurement, with the ulceration of nodules and a hanging lower lip. Hands 
and feet are ulcerated, and fingers are swollen. There are nodules on the 
nipples, and plaques covering the lower back, shoulders and arm are ulcerated, 
with hair loss.
Extended Data Fig. 3 | Disease progression of leprosy in an adult male 
chimpanzee at TNP (Woodstock) over the course of 2 years (2018–2020)  
(a–i) and an adult female chimpanzee at TNP (Zora) over the course of 
2008–2009 ( j–m). a, 2017/01 – Woodstock before the appearance of clinical 
signs. b, 2018/06 – First hypopigmented nodules appear on the face (arrows), 
with swelling and hypopigmentation on both hands, and ulceration on the right 
hand. c, 2018/10 – Existing nodules increase in size and new smaller ones 
appear (arrows). Development of mucopurulent discharge from the left eye, 
and lower eyelid is turned outward. Hair loss and ulceration on dorsal part of 
right wrist and hand. d, 2019/04 – Most existing nodules increase in size and 
become pedunculated, and the nodule under the eye shrinks, and several new 
nodules appear (see arrows). Suspected start of nasal involvement, and right 
ear starts to become disfigured. Both hands are slightly swollen and 
hypopigmented, with the loss of nail plate on the fourth finger of the left hand, 
and the third and fifth fingers show early stage of abnormal nail overgrowth.  
e, 2019/10 – Facial lesions increase in size, and some become darkly pigmented. 
New lesions appear on the brow ridge, with nodules above the lips and between 
the lips, and the nose becomes pedunculated. The loss of nail plate, and nail 
bed becomes exposed on the first and second fingers of the left hand.  
f, 2020/04 – In general, facial nodules seem smaller than before, and the nodule 
under the left eye disappears. On the left hand, the nail of the fourth finger 
shows an advanced stage of abnormal nail overgrowth, and the third and fifth 
fingernails show early stage of abnormal nail overgrowth. g, 2020/07 – Facial 
nodules seem larger with many hypopigmented, and both ears are swollen and 
disfigured. Nasal involvement becomes apparent. Both hands are swollen and 
hypopigmented. Skin ulcerations present on the right hand, with possible claw 
hand on the left hand. h, 2019/04 – Slight hypopigmentation of scrotum.  
i, 2020/07 – Reddening and ulceration of scrotum; fresh blood observed.  
j, 2007/12 – Zora before the appearance of clinical signs of leprosy. k, 2008/01 – 
Appearance of nodules on the right ear and both eyebrow ridges. l, 2008/12 – 
Appearance of nodules on the left ear, and ulceration of the skin at the second, 
third and fourth proximal interphalangeal joint level of the right hand.  
m, 2009/04 – Nodular lesions on both ears and brow ridge seem aggravated, with 
nodular lesions on the lips, and above the mouth (four months before death).
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Extended Data Fig. 4 | Confirmation of leprosy infection in Zora through 
histopathology of skin sample and lateral flow test. a, Lepromatous leprosy, 
skin with diffuse histiocytic infiltrate in the dermis. The haematoxylin and 
eosin stain was conducted once; scale bar, 500 µm. b, Lepromatous leprosy, 
skin, acid-fast bacilli in histiocytes. The inflammatory infiltrate consists 
predominantly of histiocytes admixed with fewer lymphocytes. Histiocytes 
show foamy or vacuolated cytoplasm and containing bacteria surrounded by a 
clear zone. Fite-Faraco stain; scale bar, 20 µm. Fite-Faraco stain was conducted 
once and was controlled by a positive control slide containing mycobacteria.  
c, whole blood from Zora (1) and the positive control (2). d, whole blood from a 
chimpanzee at TNP (Olivia) not infected with M. leprae, used as negative 
control. C, control lane; T, test lane.
Extended Data Fig. 5 | Geographical distribution of M. leprae genotypes in 
Africa based on genome data. The genotype 2F has never been reported in 
West Africa and is the least identified in Ethiopia. The genotype 4N/O was only 
reported in one human sample from West Africa. Data included only M. leprae 
genomes (Supplementary Note 5 and Supplementary Table 7). The map was 
downloaded from https://www.amcharts.com/svg-maps/ under a free licence 
and modified for the current figure in Inkscape, an open source digital 
illustration software package (https://inkscape.org).
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Extended Data Fig. 6 | Best-fitting root analysis using TempEst.
Extended Data Fig. 7 | Maximum Likelihood tree to confirm the topological 
placement of GB-CC064 and TNP-418. 286 genomes (Supplementary Table 6) 
were used, including the two new chimpanzee strains (in bold red), 500 
bootstrap replicates (value in black with the Tamura Nei model and in blue for 
the general time model) and M. lepromatosis as outgroup. Sites with missing 
data were partially deleted (80% genome coverage cutoff). a, Maximum 
Likelihood tree of the branch 2F. b, Maximum Likelihood tree of the branch 4.
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Extended Data Table 1 | The camera trap (CT) study periods with the focal chimpanzee community within Cantanhez National 
Park
The number of distinct CT locations for that study period is included (total number of CT locations = 211). Certain CT locations were used in more than one study period (Supplementary Table 1). 
For targeted CT placement if no chimpanzees were filmed for a certain period CTs were repositioned; hence not all cameras were working at the same time. The placement design of CTs was 
targeted or systematic. Targeted CTs were deployed to maximize detection of chimpanzees (such as chimpanzee drumming sites, fruiting trees and trails). Systematic CTs were placed follow-
ing a survey design maximizing independence between CT sites and chimpanzee detection. The CT mode was either set to photograph or video or both (hybrid) and CTs were active for 24 h per 
day. The start and end dates of each study period are included as well as the number of CT days. CT days are the sum of number of days for each active CT after removing days when cameras 
were inactive due to malfunctioning, batteries running out, trees falling in front of the CT or theft (total CT days = 28,993). The researcher initials are included (J.B., Joana Bessa; E.B., Elena 
Bersacola; M.R., Marina Ramon).
Extended Data Table 2 | Samples (CNP) and animals (TNP) that tested positive for M. leprae DNA
Samples are considered as PCR-positive if they were positive either in the RLEP or in the RLEP and the 18-kDa assay (see Supplementary Table 2 for additional information).
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Extended Data Table 3 | Primers used for the identification of M. leprae in chimpanzee tissues and faeces, diet analysis, the 
genotyping of M. leprae strains and confirmation of chimpanzee origin of the samples
Fwd, forward; Rev, reverse. *Mutation C1193T in ml0048 (genome position 60123); a T is found in TNP-418 and TNP-566. **Mutation C319T in ml0565 (genome position 683097); a T is found in 
TNP-418 and TNP-566.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
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A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
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Give P values as exact values whenever suitable.
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Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection No software was used
Data analysis All raw reads were adapter- and quality-trimmed with Trimmomatic v0.35. The quality settings were “SLIDINGWINDOW:5:15 
MINLEN:40”. Paired-end (PE) data were additionally processed with SeqPrep (https://github.com/jstjohn/SeqPrep) to merge overlapping 
pairs. Preprocessed reads were mapped onto the M. leprae TN reference genome (GenBank AL450380.1) with Bowtie2 v2.2.5.  
SNP calling was done using VarScan v2.3.9. To avoid false-positive SNP calls the following cutoffs were applied: minimum overall 
coverage of five non-duplicated reads, minimum of three non-duplicated reads supporting the SNP, mapping quality score >8, base 
quality score >15, and a SNP frequency above 80%. InDel calling was done using Platypus v0.8.1 followed by manual curation. We used 
the Integrative Genomics Viewer v 2.8.13 and Basic Local Alignment Search Tool (BLAST) v 2.11.0+. Dating analyses were done using 
BEAST2 v2.5.2.  
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- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
Sequence data are available from the NCBI Sequence Read Archive (SRA) Bioproject PRJNA664360 Biosamples SAM16207289-16207321. Biosample codes for all 
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samples used in this study are given in the Supplementary Data. Other relevant data supporting the findings of the study are available in this published article and 
its Supplementary Information files.
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For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Ecological, evolutionary & environmental sciences study design
All studies must disclose on these points even when the disclosure is negative.
Study description Study description – We report on leprosy-like lesions in two wild populations of western chimpanzees in the Cantanhez National Park 
(CNP), Guinea-Bissau, and the Taï National Park (TNP), Côte d’Ivoire, West Africa. We screen chimpanzee faecal and necropsy 
samples for the presence of M. leprae and conduct phylogenomic comparisons with other strains from humans and other animals.
Research sample The research sample is represented by two populations of wild chimpanzees (Pan troglodytes verus) in CNP and TNP. We conducted 
this study in these two populations in response to leprosy-like lesions observed during behavioural monitoring. We did not 
discriminate between age and sex classes, instead we collected data on as many individuals as possible for analysis of leprosy 
symptoms. Analyses in this paper focus on symptomatic individuals. These two chimpanzee populations include male and female 
individuals and age estimates range from newborn to adult (~40 years of age). There are a minimum of 12 chimpanzee communities 
at CNP, all unhabituated to researchers, with approximately 35-60 individuals per community (age and sex composition of all 
communities unknown). At one community (Caiquene-Cadique), we estimate at least 48 individuals, including 16 adult females, 13 
adult males, 3 subadults and 16 immatures (juveniles and infants). At TNP, the three human-habituated chimpanzee communities 
include a total of 91 individually recognised chimpanzees. 
Sampling strategy We performed non-invasive sampling through the collection of faeces from symptomatic and asymptomatic chimpanzees at CNP and 
TNP. In CNP, where chimpanzees are not habituated to human observers, this is performed by collecting faecal material found under 
chimpanzee nests or in proximity to chimpanzee signs (e.g. food remains or knuckle prints). At the time of faecal collection, the 
identity of the chimpanzee was not known. At CNP, camera traps were deployed at 211 locations including across different habitat 
types within the home range of eight of the 12 putative chimpanzee communities. Targeted camera traps were deployed to record 
and monitor chimpanzee behaviour and disease occurrence. Systematic camera traps were deployed across central CNP at a 
minimum distance of 1km between sampling points. At TNP chimpanzees are followed by researchers on a daily basis and faeces are 
collected right after observing defecation. In both cases, faeces are collected with the aid of a plastic or wooden spatula and placed 
in 2ml or 15ml tubes dry or with RNAlater. For this study we analysed all available faecal samples from individuals which displayed 
clinical signs of leprosy and optimal sample sizes could not be determined beforehand. For TNP we included only samples from the 
South community since leprosy was observed only in members of this chimpanzee community. Necropsies on dead chimpanzees 
were performed by trained veterinarians at TNP as part of the health monitoring program. For this study, we tested all available 
chimpanzee necropsy samples in our collection. 
Data collection Data collection was performed by local field assistants, researchers and veterinarians working at CNP and TNP. At CNP, clinical data 
on unhabituated chimpanzees were collected using camera traps and faecal samples were collected with the aid of a wooden spatula 
and stored at ambient temperature in 15ml tubes containing NAP buffer. At TNP, data were collected by research assistants both on 
paper sheets and using the Cybertracker app, and by veterinarians who documented via pictures and videos. At TNP, the long-term 
health monitoring program includes continuous collection of faecal and urine samples from known adult chimpanzees. Faeces are 
transferred in 2ml cryotubes with the aid of a plastic spatula and frozen in liquid nitrogen. A full necropsy is systematically performed 
on chimpanzees found dead by the on-site veterinarian. Tissue samples of several internal organs are taken if the state of carcass 
decomposition allows.
Timing and spatial scale Camera traps were set up over six data collection periods ranging from 2015 to 2019 across CNP (1067 km2). There were six study 
periods in total: (1) 13.09.15-16.12.15 (984 camera trap (CT) days, targeted CT placement, 2 communities); (2) 17.10.16-05.03.17 
(3237 CT days, systematic, 7 communities); (3) 03.06.17-15.11.17 (4435 CT days, systematic, 6 communities); (4) 09.07.17-05.07.18 
(6838 CT days, systematic, 1 community); (5) 20.02.17-08.07.18 (8023 CT days, targeted, 4 communities); (6) 03.07.18-14.04.19 
(5476 CT days, targeted and systematic, 6 communities). Data collection was stopped once we had obtained sufficient camera trap 
footage to determine leprosy presence across chimpanzee communities. Since 2020, the Cantanhez Chimpanzee Project has 
continued monitoring the health of this population. At TNP sample collection for the project started in 1994 and has been routinely 
carried out ever since. Over 25 years we have accumulated a collection of chimpanzee faecal and urine samples and necropsy 
samples from all wildlife found dead in the area. For this study, we tested samples collected between 1998 and 2019. 
Data exclusions No specifica data were excluded from the study.
Reproducibility To confirm our results of leprosy infection we used two PCR systems in parallel and tested several samples for each individual/
community. Positives were then further confirmed via next generation sequencing. For this purpose several individual libraries were 
generated to confirm M. leprae DNA presence in the samples.
Randomization Randomization is not relevant for this type of study, which is based on investigating infectious causes of illness in wildlife. To 
maximize our chances of pathogen detection we sampled all individuals, whenever possible.
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Blinding Not applicable to this study since this is a study on a naturally occurring disease in wild animals.
Did the study involve field work? Yes No
Field work, collection and transport
Field conditions Guinea-Bissau (36,125 km2), West Africa, lies within the Guinean forest-savannah mosaics, a biodiverse ecoregion buffering the 
Guinean moist forests in the south and the West Sudanian savannah in the north. The climate in Guinea-Bissau is characterized 
by a rainy season from mid-May to the end of October and a long dry season from November to mid-May. Cantanhez NP (N11° 
14.287ʹ W15° 02.281ʹ) comprises the Cubucaré peninsula in the Tombali Region bordering Guinea-Conakry. The landscape in 
Cantanhez NP consists of a mosaic of coastal sub-humid forest patches, mangroves, savannah grassland, woodland and 
agriculture including mostly cashew orchards, shifting cultivation fields and mangrove swamp rice fields. Approximately 24,000 
people across 200 villages and settlements are present inside the park. The TNP (5,082 km 2), located in the south-west of Ivory 
Coast bordering Liberia (N5° 38 56 W7° 05 43), consists of an evergreen lowland rainforest and is the largest remaining primary 
forest fragment in West Africa. It is home to a wide range of mammals that include 11 different nonhuman primate species. 
There are no settlements or agricultural areas inside the National Park. The climate in TNP is characterized by a rainy season 
from March/April to the end of October and a dry season from November to February/March.
Location Tai National Park, Ivory Coast and Cantanhez National Park, Guinea Bissau
Access and import/export Research conducted at CNP is authorised by the Institute for Biodiversty and Protected Areas (IBAP) in Guinea-Bissau, who are 
partners and co-authors on this research. All research at TNP is conducted under the umbrella of a collaboration with Ivorian 
partners and health authorities. Samples are routinely exported to Germany for diagnostic purposes following international 
guidelines and prior official authorization through CITES permits, where necessary. CITES permits for importing necropsy samples 
from Ivory Coast are regulary issued to the RKI. The most recent ones were issued on March 30th 2021 under the number DE-
E-05895/20 and DE-E-05896/20.
Disturbance All activities conducted for this study were carried out as part of the Cantanhez Chimpanzee Project and the Tai Chimpanzee 
Project. All samples and observations collected are done with the minimum disturbance to wildlife and the environment. At CNP, 
camera traps are used to collect data and cause minimum disturbance to chimpanzees. Faecal samples are collected when 
animals are no longer at the site. At TNP, a minimum distance of 7 meters is maintained from chimpanzees and samples are 
collected after the animals have moved away. Only non-invasive samples such as faeces and urine are collected.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems












Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals This study did not involve laboratory animals.
Wild animals At CNP, chimpanzees are not habituated to human observers and all data are collected remotely using camera traps. The age 
and sex distribution of chimpanzees within this population have not be calculated (as this requires accurately identifying all 
individuals). At one community (Caiquene-Cadique), we estimate at least 48 individuals, including 16 adult females, 13 adult 
males, 3 subadults and 16 immatures (juveniles and infants). At TNP, wild chimpanzee communities have been habituated by 
researchers since 1979. A team of field assistants and researchers follow the animals on a daily basis from a 7-meter distance, 
recording behavioural data and collecting faeces and urine samples whenever possible. In normal situations, each assistant or 
researcher has one focal individual per day to collect data and samples from. In disease outbreak situations, monitoring efforts 
are reinforced and sampling is attempted from all symptomatic and asymptomatic individuals. These populations include male 
and female individuals and estimation of age range is from newborn to adult (~40 years of age). As of March 2021, there are 91 
individuals (40 males and 51 females), including 43 adults (14 males and 29 females), 5 adolescents (4 males, and 1 female), 19 
juveniles (6 males and 13 females), and 24 infants (16 males and 8 females).
Field-collected samples At CNP, chimpanzee faecal samples are collected by visiting chimpanzee nesting and feeding sites. Faecal samples were stored at 
room temperature in 15ml tubes containing NAP buffer, and shipped to Robert Koch Institute in Germany. At TNP, samples are 
4





collected upon defecation or urination of the chimpanzees and stored in 2ml cryotubes. The research camps of the Tai 
Chimpanzee Project are equipped with liquid nitrogen tanks for storage of samples. Samples are then transported to Abidjan for 
temporary storage at the Centre Suisse de Recherches Scientifiques and subsequently shipped to RKI on dry ice whenever 
someone is traveling. Since these samples were collected from wild living animals, no other parameter needs to be specified (e.g. 
housing or photoperiod).
Ethics oversight All data were collected in accordance with Best Practise Disease and Monitoring Guidelines of the Great Ape Section of IUCN 
Primate Specialist Group. The collection of samples was strictly non-invasive. All proposed data collection and analyses adhered 
strictly to ethics guidelines of the Association for the Study of Animal Behaviour (UK). Ethical approval for targeted leprosy 
camera trap surveys and faecal sample collection at CNP, Guinea-Bissau, was granted by the University of Exeter, UK. The 
Institute for Biodiversity and Protected Areas (IBAP) in Guinea-Bissau approved and collaborated directly on all aspects of this 
research. Ethical approval for the work at Tai Chimpanzee Project was given by the Ethics Commission of the Max Planck Society. 
The Centre Suisse de Recherches Scientifiques en Côte d’Ivoire collaborates on the research at TNP.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants
Population characteristics M. leprae strains were collected from skin samples of newly diagnosed patients with positive bacillary index. These were 
obtained from the respective National Leprosy Control Programs in the framework of the leprosy drug resistance surveillance 
programs. Among the 21 patients included retrospectively in this study, seven were female and 13 were male (one unknown), 
ranging from 18 to 80 years in age. They originated from Mali (n=8), Benin (n=6), Niger (n=5), Côte d’Ivoire (n=1) and Senegal 
(n=1). 
Recruitment Patients were not recruited for this study. Inform consent were collected by the respective National Leprosy Control Programs 
during diagnosis to allow the use of the M. leprae strain genetic informations. 
Ethics oversight This study was carried out under the ethical consent of the WHO Global Leprosy Program surveillance network. All subjects gave 
written informed consent in accordance with the Declaration of Helsinki.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
